Jonathan A. Werner

3.3k citations
37 papers · 2.4k · 1 hit paper · h-index 13

Impact in

  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Pancreatic and Hepatic Oncology Research
    • Peptidase Inhibition and Analysis
    • Cancer Genomics and Diagnostics

Papers in

    • Immunotoxicology and immune responses 5
    • Mast cells and histamine 3
    • Animal testing and alternatives 4

Jonathan A. Werner

33 papers receiving 2.4k citations

Jonathan A. Werner's Hit Papers

The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity 2019 · 1.7k citations
1.7k0+2+4Years since publication50010001.5k

Peers

Jonathan A. Werner
Comparison fields: 5 of 100
  • Oncology 914
  • Cancer Research 275
  • Molecular Biology 1.2k
  • Pulmonary and Respiratory Medicine 491
  • Immunology 240
Replace Kenneth Daniel Kolinsky with:
Kenneth Daniel Kolinsky United States
Pawel Karol Mazur United States
Jessica R. Frankum United Kingdom
James Watters United States
Tony H Morales United States
Lee R. Silverman United States
Audie G. Rice United States
Deborah Fran Wilsker United States
J I Johnson United States
Jonathan A. Werner relative to Kenneth Daniel Kolinsky United States Kenneth Daniel Kolinsky's profile →
Citations per field
00.5×2×4×6.0×
Kenneth Daniel Kolinsky · 1×
Citations per year

Countries citing papers authored by Jonathan A. Werner

Since Specialization
Citations

This map shows the geographic impact of Jonathan A. Werner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan A. Werner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan A. Werner more than expected).

Fields of papers citing papers by Jonathan A. Werner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan A. Werner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan A. Werner. The network helps show where Jonathan A. Werner may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan A. Werner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan A. Werner Line = papers co-authored together Jonathan A. Werner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
Hit paper breakdown →
20191727
2 2020194
3 200365
4 201649
5 200444
6 200244
7 201544
8 201439
9 199933
10 201528
11 200322
12 201717
13 202113
14 202013
15 201612
16 202111
17 202310
18 200610
19 20079
20 20198

About Jonathan A. Werner

Jonathan A. Werner is a scholar working on Immunology, Small Animals, Parasitology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 37 papers that have together received 2.4k indexed citations. Recurring topics across this work include Immunotoxicology and immune responses (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Bartonella species infections research (4 papers), Animal testing and alternatives (4 papers), CAR-T cell therapy research (3 papers), Computational Drug Discovery Methods (3 papers), Veterinary Oncology Research (3 papers) and Mast cells and histamine (3 papers). The work is most often cited by research in Oncology (914 citations), Cancer Research (275 citations), Molecular Biology (1.2k citations), Pulmonary and Respiratory Medicine (491 citations) and Immunology (240 citations). Jonathan A. Werner has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Tracy L. Gieger, Kenneth M. Rassnick, Margaret C. McEntee, Alain Pierre Théon, Seth T. Wallack, Sharron L. O’Neill, Mary M. Christopher, Quinton R. Rogers, Michael Sean Kent and Erik R. Wisner. Their work appears in journals such as Toxicologic Pathology, Journal of Veterinary Internal Medicine, Nature, Molecular Cancer Therapeutics and MedChemComm.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact